Regenerative Medical Technology RMTG
OTC RMTG
$0.03 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Regenerative Medical Technology (RMTG) Net Equity Issued and Repurchased (2022)

Updated

Regenerative Medical Technology (RMTG) reported Net Equity Issued and Repurchased of -$160,000 for FY2020.

Analysis

Regenerative Medical Technology (RMTG) Net Equity Issued and Repurchased (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Regenerative Medical Technology 412,169.03 -4.11 Mn 2.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 251,536.00
API Access

Regenerative Medical Technology Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RMTG&period=max&api_key=YOUR_API_KEY